Deep Intelligence Across Industries

Company Headquarters: Alhama de Murcia, Murcia, Spain Founded: 1991 Workforce: ~200 Company Working: Kinsy SL is an independent chemical company headquartered in Spain. The company has a strong emphasis on the development and manufacturing of key APIs under the CGMP guidelines and manufacturing fine chemicals. The company’s primary focus is the development and synthesis of fine chemicals and pharmaceutical intermediates.

Company Headquarters: Italy Founded: 2005 Workforce: ~200 Company Working: Istituto Biologico Chemioterapico SpA is one of the leading organizations that manufacture APIs. It manufactures APIs, pharmaceutical intermediates, and others.

Company Headquarters: Italy Founded: 1949 Workforce: ~200 Company Working: Industria Chimica Emiliana SRL manufactures and markets pharma, bacteriological, and feed grade acids in Italy. The company’s products offering include, chenodeoxycholic, cholic, dehydrocholic, deoxycholic, disuccinylursodeoxycholic, hyodeoxycholic, & ursodeoxycholic acids; and bisodic & trihydrate magnesium salts, methyl ester, natural taurine, and sodium dehydrocholate. It has an established worldwide network and controls the collection of ox-bile from the main producing countries.

Company Headquarters: Tokyo, Japan Founded: 1953 Workforce: ~203 Company Working: Fujimoto Chemicals is a wholesale distributor of chemicals and allied products across the globe. Its key focus lies on the production of chemicals and APIs. The company manufactures and develops various products such as APIs, pharmaceutical intermediates, dyestuffs, industrial chemicals, fats & oils, food & food additives, and cosmetic bases & perfumes.

Company Headquarters: San Paolo d'Argon, Italy Founded: 1974 Workforce: ~230 Company Working: Erregierre SpA is an Italian company manufacturing APIs for pharmaceutical purpose. It provides APIs for treatment of various disorders such as cardiovascular, central nervous system, and treatment of other therapeutic categories. It serves customers in pharmaceutical and generic industries in North America, Europe, Japan, and internationally

Company Headquarters: Baranzate, Milan, Italy Founded: 1949 Workforce: ~500 Company Working: Dipharma Francis SRL is a manufacturer of APIs in Europe. It offers APIs and custom-synthesis services worldwide. It serves pharmaceutical companies in North America, Europe, and Japan. It is manufacturer APIs, pharmaceutical intermediates, and has a portfolio of more than 50 products, with drug master files lodged worldwide.

Company Headquarters: US Founded: 1935 Workforce: ~1000 Company Working: Alchem International Ltd is a manufacturer of phytochemicals and has an experience of over 75 years in providing plant-derived active ingredients to the pharmaceutical, cosmetic, and nutraceutical industries across 35 countries globally. The company has three manufacturing sites across India and four international divisions with offices in India, Europe, Hong Kong, and the United States. Alchem International Ltd has filed regulatory dossiers in over 20 countries.

Company Headquarters: Massachusetts, US Founded: 2015 Workforce: ~370+ Company Working: Mustang Bio is a subsidiary of Fortress Biotech, Inc. It is a clinical‐stage biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient’s immune system to eliminate cancer cells. Mustang Bio aims to acquire rights to these technologies by licensing or otherwise acquiring an ownership interest, funding research and development, and out-licensing or bringing the technologies to market. Mustang has partnered with the City of Hope National Medical Center (COH) and Fred Hutchinson Cancer Research Center in the development of proprietary CAR T therapies for many cancers. Mustang Bio’s lead programs are in Phase 1 clinical trials at COH: MB-101 for the treatment of brain cancer and MB-102 as a therapeutic agent in acute myeloid leukemia

Company Headquarter: ‎ California, US Founded: 1989 Workforce: ~200 Company Working: Sorrento Therapeutics (Sorrento) is an antibody-centric, clinical stage biopharmaceutical company that develops new treatments for cancer, inflammation, and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar antibodies, as well as clinical CAR-T therapies targeting solid tumors. It has a unique immuno-oncology (I-O) portfolio, comprised of a wide array of innovative and synergistic assets, such as a broad fully human antibody library (G-MAB), clinical stage CAR-T, intracellular targeting antibodies (iTAbs), antibody-drug conjugates (ADC), and an oncolytic virus (Sephrehvir).